DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Online

What’s the Key to Digital Transformation in Biopharma R&D?

概览

Brought to you by DIA in cooperation with

Microsoft


Biopharmaceutical companies clearly express the desire to adopt digital technologies in an effort to accelerate clinical development. COVID-19 has served to underscore the need for digitalization for business continuity and virtual data access, for employees, collaboration partners and patients. This webinar will share insights gained from more than 250 biopharma executives on implementation and adoption of digital technologies in biopharma R&D across four areas – strategy, value, progress and barriers to adoption. We’ll share insights from these executives as well as our observations and experience working with life sciences companies as well as companies in other industries prove that change will happen.


精选主题

  • Digital strategy
  • Hurdles to adoption of digital capabilities
  • Digital technologies

谁应该参加?

Professionals who work in the area of:

  • Biotechnology
  • Clinical Data Management/eClinica
  • Clinical Research
  • Clinical Safety and Pharmacovigilance
  • Technology Assessmen
  • Medical Devices and Diagnostics
  • Patient Engagement
  • Rare, Orphan Diseases
  • Research & Develop/Strategic Issues

学习目标

Upon completion of the webinar, participants will have a better understanding of:

  • How the biopharmaceutical industry evaluates their maturity in adopting digital capabilities
  • How digital can help R&D organizations achieve their strategic imperatives
  • What the most common barriers are to digital adoption in biopharma R&D
  • What steps R&D organizations can take to help ensure they are getting scaling the right digital capabilities and realizing the most value from these capabilities


Continuing Education Credits are not available for this event.


获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。